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Abstract 
Increased phosphorylation of the 70 kDa ribosomal S6 kinase (p70s6k) signaling is strongly 
correlated with the degree of muscle adaptation following exercise. Here, we compare the 
phosphorylation of p70s6k, Akt and mTOR in the tibialis anterior (TA) muscles of lean and obese 
Zucker rats following a bout of eccentric exercise. Exercise increased p70S6k (Thr 389) 
phosphorylation immediately after (33.3 ± 7.2%) and during recovery [1-hr; (24.0 ± 14.9%), and 
3-hr (24.6 ± 11.3%)], in the lean TA and at 3-hr (33.5 ± 8.0%) in the obese TA. mTOR (Ser 2448) 
phosphorylation was elevated in the lean TA immediately after exercise (96.5 ± 40.3%) but 
remained unaltered in the obese TA. Exercise increased Akt (Thr 308) and Akt (Ser 473) 
phosphorylation in the lean but not the obese TA. These results suggest that insulin resistance is 
associated with alterations in the ability of muscle to activate p p70s6k signaling following an 
acute bout of exercise. 
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INTRODUCTION 
 
Type 2 (non-insulin dependent) diabetes mellitus (DM) is an emerging epidemic in Western 
cultures that is thought to afflict 150 million people worldwide 11. Insulin resistance is 
frequently accompanied by a variety of metabolic and cardiovascular abnormalities that 
include hypertension, glucose intolerance, Type 2 diabetes, dyslipidemia, atherosclerosis 
and central obesity. A number of studies that employ strength training regimens have been 
shown to improve glycemic control, increase skeletal muscle size and strength, and 
positively change body composition. They suggest that anaerobic exercise may be an 
effective strategy for the treatment of insulin resistance and type 2 diabetes 6,7,49,53. 
Recent reports have suggested that differences exist between normal and insulin resistant 
muscle in their adaptation to an exercise regimen 8,5,50,20,24,48. However, the direct 
effects of exercise on the phenotype of insulin resistant muscle have not been widely 
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studied. It is thought that the beneficial effects of exercise on muscle are mediated through 
activation of various signaling cascades which are involved in regulating changes in gene 
expression, glucose uptake, and protein synthesis 2. Whether insulin resistance alters 
exercise-induced signal transduction processes in muscle is unknown, but the existence of 
differences, if present, may help to explain why exercise-induced skeletal muscle 
adaptations may differ between normal and insulin resistant populations. 
 
It is well established that increased muscle loading increases the rates of muscle protein 
synthesis 27. This increase in protein synthesis, at least in part, is thought to be regulated by 
the phosphorylation of the p70 ribosomal protein S6 kinase (p70S6k) 26, whose activation 
has been proposed to promote increased translation of messages that have a polypyrimide 
motif just downstream of the 5′ cap 45. It is thought that p70S6k activity is regulated by the 
mammalian target of rapamycin (mTOR), which functions as a growth factor and nutrient- 
sensing signaling molecule in mammalian cells 40. How mTOR activity is modulated is not 
clear; however, recent evidence suggests that mTOR is controlled by Akt or protein kinase B 
(PKB) which is activated in response to phospholipid products of the phosphatidylinositol 3- 
kinase (PI3K) reaction. It is well documented that binding of insulin to the membrane 
receptor stimulates a cascade of phosphorylation events resulting in activation of PI3K. It is 
likely that PKB/Akt directly increases mTOR activity by phosphorylating mTOR at 
Ser2448, and it has been hypothesized that this event is a critical point of control in the 
regulation of protein synthesis 4. It has been postulated that p70S6k signaling may be 
particularly important in mediating muscle adaptation given that the phosphorylation of this 
molecule following an exercise bout has been found to be strongly associated with the 
increase in muscle weight after 6 wk of chronic stimulation 1 
The purpose of the present study was to determine whether insulin resistance alters p70S6k 
signaling after an acute episode of contractile activity. To investigate this possibility, muscle 
signaling was examined in 12-week old lean and obese Zucker rats, as it is widely accepted 
that the insulin resistance exhibited by these animals closely models the development of type 
2 diabetes seen in humans 3,18,25,39. We hypothesized that insulin resistance would be 
associated with differences in how muscle contraction regulates the phosphorylation of the 
Akt/mTOR/p70S6k signaling cascade. To test this hypothesis, the contraction-mediated 
activation of Akt, mTOR and p70S6k was assessed either immediately after or 1 or 3h after 
a single bout of sciatic nerve stimulation. Taken together, our data suggest that insulin 
resistance alters contraction-induced p70S6k phosphorylation in skeletal muscle. These 
findings are consistent with the possibility that insulin resistance alters the way skeletal 
muscle “senses and responds” to contractile stimuli. 
 
 
METERIALS AND METHODS 
 
       Animal Care 
 
All procedures were performed as outlined in the Guide for the Care and Use of Laboratory 
Animals as approved by the Council of the American Physiological Society and the Animal 
Use Review Board of Marshall University. Young (10 week, n=12) male lean Zucker and 
young (10 week, n=12) male obese Zucker rats were obtained from the Charles River 
Laboratories. Rats were housed two to a cage in an Association for Assessment and 
Accreditation of Laboratory Animal Care (AAALAC) approved vivarium. Housing 
conditions consisted of a 12H: 12H dark-light cycle, and temperature was maintained at 22° 
± 2°C. Animals were provided food and water ad libitum and allowed to recover from 
shipment for at least two weeks before experimentation. During this time the animals were 
carefully observed and weighed weekly to ensure that none exhibited signs of failure to 
thrive, such as precipitous weight loss, disinterest in the environment, or unexpected gait 
alterations. 
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Materials 
 
 
Anti- p70S6k (#9202), Akt (#9272), mTOR (#2972), PTEN (#9552), TSC2/tuberin (#3612), 
raptor (#4978), phosphorylated Thr389 p70S6K (#9206), phosphorylated Ser421/Thr424 
p70S6K (#9204), phosphorylated Ser2448 mTOR (#2971), phosphorylated Thr308 Akt 
(#9275), phosphorylated Ser473 ( #9271) Akt, Ser380/Thr382/383 phosphorylated PTEN 
(#9554), phosphorylated Thr1462 TSC2/tuberin (#3611), Mouse IgG, and Rabbit IgG 
antibodies were purchased from Cell Signaling Technology (Beverly, MA). Enhanced 
chemiluminescence (ECL) western blotting detection reagent was obtained from Amersham 
Biosciences (Piscataway, NJ). Restore western blot stripping buffer was obtained from 
Pierce Company (Rockford, IL), and 3T3 cell lysates were from Santa Cruz Biotechnology 
(Santa Cruz, CA). All other chemicals were purchased from Sigma Biosciences (St. Louis, 
MO) or Fisher Scientific Company (Hanover, IL).
 
      Contractile stimulation of skeletal muscles 
The high-frequency electrical stimulation (HFES) model has been previously described 36 
and was chosen on the basis of its efficacy in stimulating protein translation and muscle 
hypertrophy in vivo1. In order to produce maximal contractile stimulus, a voltage of 5–7V 
was applied to electrodes placed on the sciatic nerve and the sciatic nerve was stimulated 
with 1-ms pulses at 100 Hz, where all motor units(both fast and slow) are recruited. The 
contractionslasted 3 s and were followed by a 10-s rest, and after the sixth repetition there 
was an additional 50 s of rest. The HFES model used in the present study produced 10 sets 
of 6 contractions with an overall protocol time of 22 min. This protocol results in eccentric 
contraction of the TA. The TA muscle was chosen for analysis on the basis of previous 
studies demonstrating that HFES induces p70S6k phosphorylation and muscle hypertrophy 
in the TA muscle 15,30,47,54. Animals were killed by a lethal dose of pentobarbital sodium 
at baseline, immediately following, 1h or 3 h after HFES. Once excised, muscles were 
blotted dry, trimmed of visible fat and tendon projections, weighed, immediately frozen in 
liquid nitrogen, and stored at −80° C. 
 
Preparation of protein isolate and immunoblotting 
Muscles were pulverized in liquid nitrogen using a mortar and pestle until a fine powder was 
obtained. After washing with ice cold PBS, pellets were lysed on ice for 15 minutes in 
Tissue Protein Extraction Reagent (T-PER) lysis buffer composed of T-PER reagent (2mL/ 
1g tissue weight) (Pierce, Rockford, IL), 1 mM EDTA (pH 8.0), 1 mM EGTA (pH 7.5), 1M 
magnesium chloride, 1 mM PMSF, 1μl protease inhibitor cocktail and 1 mM sodium 
vanadate to inhibit phosphatase activity and centrifuged for 10 minutes at 2000 × g to pellet 
particulate matter. This process was repeated twice, and the supernatants were combined for 
protein concentration determination using the Bradford method (Pierce, Rockford, IL). 
Samples were diluted to a concentration of 3 μg/ μl in SDS loading buffer and boiled for 5 
minutes. 60 μg of protein were separated using 10% SDS-PAGE gels. Transfer of protein 
onto nitrocellulose membranes, verification of transfer and determination of equal loading 
between lanes and membranes was determined as outlined previously 33. Protein immuno- 
detection was performed as outlined by the antibody manufacturer while immunoreactive 
bands were visualized with Electrochemiluminescence (ECL) (Amersham Biosciences). 
Exposure time was adjusted at all times to keep the integrated optical densities (IODs) 
within a linear and non-saturated range, and band signal intensity was quantified by 
densitometry using a flatbed scanner (Epson Perfection 3200 PHOTO) and imaging software 
(AlphaEaseFC) after normalization to β-tubulin. Molecular weight markers (Cell Signaling) 
were used as molecular mass standards, and NIH 3T3 cell lysates were included as positive 
controls. To allow direct comparisons to be made between the concentration levels of 
different signaling molecules, immunoblots were stripped and re-probed with Restore 
western blot stripping buffer as detailed by the manufacturer (Pierce, Rockford, IL). 
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Statistical analysis 
Results are presented as mean ± SEM. Data were analyzed by using the Sigma Stat 3.0 
statistical program. Data was analyzed using a two-way ANOVA followed by the Student- 
Newman-Keuls post-hoc testing when appropriate. P <0.05 was considered to be statistically 
significant. 
 
RESULTS 
 
Insulin resistance and muscle mass 
The average body weight of the obese Zucker rats was ~82 % greater than that of the lean 
Zucker rats (597 ± 21.7 g vs. 328 ± 12.2 g; P< 0.05). Compared to lean animals, TA muscle 
mass was ~35% less (651 ± 9.0 mg vs. 479 ± 20 mg) in the obese Zucker rats (P< 0.05) 
(Table 1). 
 
 
P70S6k pathway related protein levels and phosphorylation status are altered in the insulin 
resistant TA muscle 
 
To investigate the effects of insulin resistance on the total amounts of p70S6k, mTOR, Akt, 
PTEN, TSC2 and raptor we performed SDS PAGE and western blot analysis using 
antibodies which recognize both the unphosphorylated and phosphorylated forms of these 
molecules. There were no differences in mTOR, raptor and TSC2 protein content (P< 0.05) 
(Figs.1, 5). The muscle content of p70S6k, and Akt in the obese zucker TA was 27.9 ± 3.6% 
and 28.2 ± 10.1% lower, respectively than that observed in their lean counterparts (P< 0.05) 
(Fig. 1). The expression of PTEN was higher in obese Zucker rats by 25.63 ± 4.2% when 
compared to the lean Zucker rats (P< 0.05) (Fig. 5). Immunoblot analysis using phospho- 
specific antibodies indicated that the basal phosphorylation level of p70S6k (Thr 389) was 
26.1 ± 7.5% lower in the obese Zucker TA compared to that observed in lean animals 
(P<0.05) (Fig. 2). No differences were seen across groups in basal phosphorylation levels of 
p70S6k (Thr421/Ser424), mTOR (Ser 2448), Akt (Thr 308) Akt (Ser 473) and TSC2 (Figs. 
2, 3, 4 and 5). 
 
 
The contraction-induced phosphorylation of p70S6k is altered in the obese-Zucker rat 
 
Phosphorylation of p70S6k, mTOR and Akt in exercised TA muscles was determined at 0-, 
1-, and 3-hours after a bout of HFES and compared to control (unstimulated) muscles. 
Exercise-induced phosphorylation of these molecules was compared between lean and obese 
Zucker rats. In the case of each molecule examined, significant differences existed between 
lean and obese Zucker rats (Fig. 2, 3 & 4). In the lean rat TA, the phosphorylation of p70S6k 
(Thr 389) was found to be 33.3 ± 7.2%, 24.0 ± 14.9% and 24.6 ± 11.3% higher than in 
unstimulated control muscles at 0-, 1- and 3-hr post-HFES, respectively (P< 0.05) (Fig. 2). 
This response appeared to differ in the obese Zucker TA, where the phosphorylation of 
p70S6k (Thr 389) was 33.5 ± 8.0% higher than control 3hr post-exercise (P<0.05), but not 
immediately after or at the 1 hr post-HFES (Fig. 2). In lean Zucker TA, the Erk1/2- 
dependent phosphorylation of p70S6k (Thr 421/Ser 424) was 412.5 ± 37.2%, 331.0 ± 28.1% 
and 83.0 ± 20.7% higher than control at 0-, 1- and 3-hr, respectively (P< 0.05) (Fig. 2). 
Although different in magnitude compared to lean animals (Fig. 2) p70S6k (Thr 421/Ser 
424 ) phosphorylation in the obese TA exhibited a similar pattern and was 294.5 ± 9.6%, 
103.3 ± 35.5% and 182.0 ± 26.1% higher than baseline at 0-, 1- and 3-hours, respectively 
(Fig 2; P< 0.05) 
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Contraction-induced phosphorylation of potential p70S6k regulators is 
altered in the obese Zucker rat 
 
It is thought that p70S6k phosphorylation is regulated by the mTOR complex and its 
upstream regulator Akt 4,40,41. mTOR phosphorylation (Ser 2448) was found to be 96.5 ± 
40.3% higher than baseline immediately after exercise in lean animals (P< 0.05), while it 
was not different from baseline at 1 and 3 hr post-HFES (Fig. 3). This response differed in 
obese animals with no alteration in mTOR (Ser 2448) phosphorylation levels at any time 
point after HFES (Fig. 3). There was no significant difference between contraction-induced 
TSC2 (Thr 1462) phosphorylation in obese Zucker rats compared to their lean counterparts 
(Fig. 5). In the lean Zucker TA, Akt (Thr 308) phosphorylation was 31.8 ± 16.2%, 29.8 ± 
7.5% and 31.1 ± 8.8% higher than baseline at 0-, 1- and 3-hr post-HFES, exhibiting a 
biphasic response (P<0.05; Fig. 4). An altogether opposite response was observed in the 
obese Zucker TA, where Akt (Thr 308) phosphorylation was 25.3 ± 6.2%, 44.6 ± 9.0% and 
30.4 ± 5.9% lower than baseline at 0-, 1-, and 3-hours, respectively after HFES (P<0.05). In 
lean rats the phosphorylation of Akt (Ser 473) appeared to mirror what was seen at the Thr 
308 residue with HFES and was 47.2 ± 12.1% and 43.7 ± 11.7% higher than baseline at 0- 
and 3-hours, respectively (P< 0.05) (Fig. 4). This pattern of response was essentially 
opposite in the obese Zucker rats, where the phosphorylation of Akt (Ser 473) was 18.7 ± 
6.4%, 46.3 ± 5.5% and 32.4 ± 7.3% lower than baseline at 0-, 1-, and 3-hours post-HFES, 
respectively (P< 0.05) (Fig. 4). Taken together these results suggest that the contraction- 
induced activation of p70S6k signaling may be altered with insulin resistance. 
 
DISCUSSION 
 
The obese Zucker rat is insulin resistant and has been used as a model of type 2 diabetes 
10,22. In this report we demonstrate that the phosphorylation (activation) of the Akt/mTOR/ 
p70S6k pathway in response to a maximal contractile stimulus appears to be altered in 
insulin resistant muscle. 
 
Our results suggest that, compared to lean animals, the magnitude and time course of the 
contraction-induced phosphorylation of p70S6k (Thr 389) and p70S6k (Thr 421/ser 424) 
was significantly different in obese animals (Fig. 2). The p70S6k is a serine/threonine 
protein kinase, and it has been shown to play an important role in regulating protein 
synthesis. It is thought that p70S6k modulates protein synthesis, at least in part, by 
controlling the translation of numerous messenger RNA transcripts that encode components 
of the translational apparatus 38. Illustrating this fact is the finding that blockade of p70S6k 
activity results in significant inhibition of protein synthesis in multiple cell systems 
12,23,9,32,55. In skeletal muscle, the contraction-induced phosphorylation of p70S6K has 
been found to be elevated following HFES 1,37,36 and is highly correlated with an increase 
in muscle mass following a resistance training program 1. To our knowledge, the influence 
of diabetes on p70S6k phosphorylation in response to muscle contraction has not been 
reported before. The physiological significance of these alterations remains unclear; 
however it is interesting to note that previous reports have suggested that the insulin- 
stimulated phosphorylation of p70S6k may be altered in diabetic rats 19,14,29. In the light 
of these studies, our data suggest that insulin resistance may affect how multiple stimuli may 
regulate the phosphorylation of p70S6k. Future studies that employ a combination of 
approaches to stimulate p70S6k phosphorylation will certainly be of value in determining 
how insulin resistance may affect the regulation of p70S6k in skeletal muscle. 
 
To further explore how insulin resistance may be associated with alterations in the 
contraction-induced regulation of p70S6k phosphorylation, we assessed the effects of 
muscle contraction on mTOR. Like p70S6k, mTOR is thought to be involved in regulating 
several components of the translational machinery and in addition, it is thought to be an 
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upstream activator of p70S6k 16. Similar to previous studies, increased contractile activity 
appears to be a strong stimulus to increase the phosphorylation level of mTOR in non- 
diabetic muscle 37,36. Conversely, in the insulin resistant TA, HFES appears to be unable to 
alter the degree of mTOR phosphorylation (Fig. 3). This latter finding is consistent with our 
data that demonstrate that insulin resistant muscle exhibits a reduced ability to activate 
p70S6k following a bout of HFES. Taken together, these data suggest that insulin resistance- 
associated alterations in p70S6k regulation may be due, at least in part, to defects in the 
ability of diabetic muscle to activate mTOR following a contractile stimulus. 
 
It is thought that mTOR phosphorylation of Ser 2448 is directly regulated by Akt/PKB 
41,43,44. Akt is a serine/threonine kinase that has been shown to mediate certain types of 
muscle hypertrophy 4. Under non-stimulated conditions Akt is located in the cytoplasm. It is 
thought to translocate to the plasma membrane upon activation, where it is phosphorylated 
by phosphinositide-dependent kinases (PDK) on its two principal regulatory sites Thr 308 
and Ser 47352. Like p70S6k and mTOR, HFES significantly increased the amount of Akt 
(Ser 308) and Akt (Ser 473) phosphorylation in non-diabetic muscle (Fig 4). Similar 
findings regarding the effects of contractile activity on Akt phosphorylation in non-insulin 
resistant muscle have been reported previously 34,42,51. In contrast to our findings in the 
non-insulin resistant animals, these events appeared to differ in insulin resistant muscle. This 
suggests that insulin resistance is associated with alterations in the ability of skeletal muscle 
to activate Akt signaling following increased contractile loading (Fig. 4). Given that Akt is 
thought to reside upstream of mTOR, this lack of Akt activation in insulin resistant muscle 
may provide an explanation as to why insulin resistance may be associated with defects in 
HFES induced mTOR and p70S6k phosphoryation. 
 
In an attempt to explain differences in contraction-dependent signaling between models we 
also examined how HFES affected the regulation of raptor (a positive regulator of mTOR 
activity), the Akt inhibitor, phosphatase and tensin homolog (PTEN), and the mTOR 
repressor, tuberin (TSC2) 28. The ability of PTEN and TSC2 to inhibit downstream 
signaling is thought to be regulated by phosphorylation 57,56 while differences in raptor 
levels between models could influence mTOR activation. Our findings of no differences in 
the regulation of these three molecules with HFES between models suggests that raptor, 
PTEN and tuberin may not be responsible for the differences in Akt and mTOR 
phosphorylation that we observe between normal and insulin-resistant muscle subjected to 
HFES (Fig. 5). Although not investigated here, recent work has suggested that 
phospholipase D (PLD) may play a key role in regulating load-induced mTOR 
phosphorylation in skeletal muscle 21. Whether differences in PLD regulation with insulin 
resistance can explain the alterations in mTOR signaling we see between our experimental 
models will require further experimentation (Fig. 6). 
 
The precise influence of insulin resistance on Akt regulation in muscle contraction remains 
unclear. It has been postulated that the degree of Akt activation following contractile activity 
may be dependent upon the type of contractile activity, contraction intensity, and/or the 
duration of stimulation 36. Given this contention, it is plausible that differences in the 
signaling response between models could be related to the time points chosen for evaluation. 
Future studies that employ other time points could yield different findings. Alternatively, it 
is possible that the two groups experienced a different amount of tension during the HFES 
protocol. Although this possibility exists, we consider it unlikely that differences in 
contractile intensity, if present, are solely responsible for the alterations in muscle signaling 
we observe. Indeed, given the nature of the HFES model (direct nerve stimulation), the type 
of contraction this model produces in the TA (maximal eccentric loading) and the conditions 
under which the loading occurred (identical in both groups), we suggest that our data are 
consistent with the notion that insulin resistance is characterized by alterations in contractile 
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signaling. The molecular mechanism(s) responsible for these differences are largely 
unknown. Exercise was found to have no effect on Akt as observed in isolated soleus 
muscle, suggesting perhaps that systemic factors and/or oxidative stress may also play a role 
in mediating the activation of Akt by exercise 46. Supporting this contention, hyperglycemia 
has been shown to directly decrease insulin-induced Akt phosphorylation on Ser473 in rat 
and human skeletal muscle 17,35. The factors which may regulate diminished Akt activation 
during hyperglycemia will require further experimentation. Similarly, it is also possible that 
reduced availability of circulating growth factors, decreased expression of local growth 
factors or alterations in cytokine levels may also play a role regulating Akt signaling 31. 
This latter possibility is an intriguing alternative that we are actively pursuing. Given the 
strong correlation between the phosphorylation level of p70S6k and degree of muscle 
hypertrophy seen by others, these data could suggest that insulin resistant muscle may be 
incapable of growth following a resistance-based exercise program. This is not in agreement 
with the findings of Farrell and colleagues who demonstrated that diabetic muscle is fully 
capable of undergoing muscle hypertrophy following 8 weeks of resistance training13. The 
reasons for this apparent discrepancy are not entirely clear, but they may lie in the difference 
in models and time points of the studies. Irrespective of the mechanism, it is likely that 
insulin resistance-associated differences in the ability of skeletal muscle to induce Akt → 
mTOR → p70S6K signaling could be of clinical importance, given the potential role that 
this signaling pathway may play in regulating protein synthesis and the adaptation of 
skeletal muscle to increased contractile loading (Fig. 6). Given the apparent linkage between 
exercise-induced increase in muscle mass and improvement in glucose disposal, we 
speculate that the data of the present study may have implications for the improvement of 
resistance based programs for the treatment of diabetes mellitus. 
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Abbreviations 
 
ECL Enhanced Chemiluminiscence 
 
HFES High Frequency Electrical Stimulation 
 
LZ Lean Zucker 
 
mTOR mammalian Target of Rapamycin 
 
PBS Phosphate Buffered Saline 
 
PTEN Phosphatase and Tensin Homolog 
 
OZ Obese Zucker 
 
p70S6k 70 kDa ribosomal S6 kinase 
 
PKB Protein Kinase B 
 
SDS-PAGE Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis 
 
TA Tibialis Anterior 
 
T-PER Tissue Protein Extraction Reagent 
 
TSC2 Tuberous Sclerosis Complex 2 
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Figure 1. 
TA muscles from lean (LNZ) and obese Zucker rats (OSXZ) were analyzed by Western blot 
analysis for diabetes-related changes in total p70S6k, mTOR and Akt protein expression. 
Protein quantifications were done after normalization by the abundance of β-tubulin protein. 
Results are expressed as a percent of the normal, LNZ value. An asterisk (*) indicates 
significant differences (P< 0.05) from the lean Zucker value. 
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Figure 2. Contraction-induced p70S6k (Thr 389 & Thr 421/Ser 424) phosphorylation is altered 
with insulin resistance 
The basal (control) and contraction-induced phosphorylation of p70S6k in TA muscles from 
lean and obese Zucker rats at 0, 1, and 3 hours after contractile stimulus. p70S6k (Thr 389 & 
Thr 421/ser 424) phosphorylation was determined by Western blot analysis and 
immunodetection for phosphorylation on Thr389 andThr421/Ser424. All the protein 
quantifications were done after normalization by the abundance of β-tubulin protein. An 
asterisk (*) indicates a significant difference (P < 0.05) from the control within-animal 
model, and a cross (†) indicates significant difference (P < 0.05) at corresponding time 
points across animal models. 
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Figure 3. Contraction-induced mTOR (Ser2448) phosphorylation is altered with insulin 
resistance 
The basal (control) and contraction-induced phosphorylation of the mTOR in TA muscles 
from lean (LNZ) and obese Zucker (OSXZ) rats at 0-, 1-, and 3-hours after HFES. 
Phosphorylation of mTOR was determined by immunodetection of phosphorylation on 
Ser2448. An asterisk (*) indicates significant difference (P < 0.05) from the control time 
point within-animal model, and a cross (†) indicates a significant difference (P < 0.05) at 
corresponding time points across animal models. 
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Figure 4. Effects of eccentric, maximal muscle contraction in situ on phosphorylation of Akt 
(Thr308/Ser473) 
The basal (control) and contraction-induced phosphorylation of the Akt in TA muscles from 
lean and obese Zucker rats at 0, 1, and 3 hours after contractile stimulus. Akt 
phosphorylation was determined by Western analysis and immunodetection for Akt 
phosphorylation on Thr308 and Ser473. An asterisk (*) indicates significant difference (P < 
0.05) from the control within-animal model, and a cross (†) indicates significant difference 
(P < 0.05) at corresponding time points across animal models. 
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Figure 5. 
Immunoblot analyses of Protein abundance of Raptor, TSC2 and PTEN and phosphorylation 
of Thr1462 on TSC2 and Phosphorylation of Ser380/Thr382/383 on PTEN in TA muscles 
from lean and obese Zucker rats at 0, 1, and 3 hours after contractile stimulus.
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Figure 6. 
Schematic diagram summarizing alterations in molecules of the signalling pathway leading 
to protein synthesis in Lean and Obese Zucker rats after High force electrical stimulation 
(HFES). Molecules shown in dark shaded, medium shaded and empty circles represent no 
change, complete and incomplete activation, respectively. Molecules shown in dashed 
rectangles were not measured in this study. 
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Table 1 
 
Body weight and muscle mass of lean and obese (fa/fa) Zucker rats. 
 
 Lean Zucker Obese Zucker 
Body mass, g 328 ± 12.2 597 ± 21.7* 
TA mass, mg 651 ± 9.0 479 ± 20* 
 
An asterisk (*) indicates significant difference (P < 0.05) from the lean Zucker value. 
